Press Releases

Magnify Magazine

Media Resources

Press Releases

microscope

Magnify Magazine

microscope

Media Resources

microscope

Pictured from left to right are Hunter Best, Tracy George, Erica Clyde, and Salika Shakir talk. The window behind them shows the ARUP campus.

Leaders of ARUP’s Innovation Business Unit discuss their latest developments. Pictured from left to right are Hunter Best, PhD, FACMG; Tracy George, MD; Erica Clyde, MBA, PMI-PMP®, MB(ASCP)CM; and Salika Shakir, PhD, D(ABMM).

 February 26, 2026 ARUP Creates Innovation Central Laboratory To Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners

ARUP’s Innovation Central Laboratory will serve as an ecosystem for validating technologies and accelerating next generation diagnostics from concept to commercialization.

ARUP logo and Rarity logo

 February 3, 2026 Rarity Bioscience Announces That ARUP Laboratories Has Become the First U.S. Reference Lab To Validate Its Ultrasensitive superRCA Assay

ARUP is the first U.S. lab to validate Rarity Bioscience’s ultrasensitive superRCA™ assay, which advances high-precision mutation detection and supports innovation in clinical and trial settings.

Adam Barker leans against a counter in a lab while smiling at the camera.

A microbiologist, Adam Barker, PhD, was ARUP's chief scientific officer and director of Research and Development before being named chief operations officer. He now adds Reference Business Unit president to his title.

 December 23, 2025 Adam Barker, PhD, Named President and Chief Operations Officer of ARUP Reference Business Unit

In his new role, Adam Barker, PhD, will lead operational innovation to support ARUP’s growth while maintaining the highest quality.

ARUP’s Robert Ohgami, MD, PhD,

ARUP’s Robert Ohgami, MD, PhD, MBA, FCAP, gave a poster presentation detailing novel research on AI-driven grading of Castleman disease histopathology.

 December 8, 2025 ARUP Experts Contributed to Castleman Disease Research Showcased by Recordati at ASH Annual Meeting

RIDGEWATER, N.J.—Recordati Rare Diseases Inc. today announced the presentation of new data detailing advances in the understanding of Castleman disease (CD), a group of rare immune system disorders characterized by abnormal lymph node enlargement and systemic inflammatory symptoms that can be potentially life threatening.

A gloved hand pipettes test tubes in a tray.

The RESULTS Act would block looming cuts in payments for lab testing services and protect patients’ access to essential lab tests.

 November 19, 2025 ARUP Advocates for the RESULTS Act To Protect Patient Access to Critical Laboratory Testing Services

The RESULTS Act offers meaningful reform to a flawed system and will ultimately benefit patients, support innovation, and create stability within the clinical laboratory community.

Blaine Mathison looks at a computer screen showing digital images of wet-mount slides.

Blaine Mathison, BS, M(ASCP), technical director of Parasitology at ARUP, reviews digital images of wet-mount slides. Mathison played a significant role in the validation of the AI screening tool for the detection of gastrointestinal parasites.

 October 21, 2025 Journal of Clinical Microbiology Publishes Article on ARUP’s Validation of AI for Parasite Detection

An article describing ARUP’s validation of an artificial intelligence (AI) solution to detect gastrointestinal parasites in wet mounts has been published in the Journal of Clinical Microbiology.